# James J. Hsieh

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-j-hsieh/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,636 |
| Field | Renal cell carcinoma treatment |
| h-index | 78 |
| i10-index | 157 |
| Last Known Institution | Washington University in St. Louis |
| OpenAlex ID | https://openalex.org/A5021734597 |
| ORCID iD | https://orcid.org/0000-0003-3595-0551 |
| Works | 385 |

## Researcher papers

- [Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-cabozantinib-versus-sunitinib-for-advanced-renal-cell-carcinoma/)
- [The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma](https://scholariq.org/papers/the-somatic-genomic-landscape-of-chromophobe-renal-cell-carcinoma/)
- [The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma](https://scholariq.org/papers/the-cancer-genome-atlas-comprehensive-molecular-characterization-of-renal-cell/)
- [Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma](https://scholariq.org/papers/integrated-proteogenomic-characterization-of-clear-cell-renal-cell-carcinoma/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

## Researcher university

- [Washington University in St. Louis](https://scholariq.org/institutions/washington-university-in-st-louis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
